Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2010

01-11-2010 | Brief Report

Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population

Authors: Jing Zhang, James D. Fackenthal, Dezheng Huo, Yonglan Zheng, Olufunmilayo I. Olopade

Published in: Breast Cancer Research and Treatment | Issue 2/2010

Login to get access

Abstract

BRCA1/2 germline mutations predispose to breast and ovarian cancer. Large genomic rearrangements (LGRs) have widened the mutational spectrum of the BRCA1 gene, but the frequencies vary in different populations. In this study, we want to determine the spectrum of LGRs in BRCA1 gene in Nigerian breast cancer patients. The multiplex ligation-dependent probe amplification (MLPA) assay was used to screen BRCA1 rearrangements in 352 patients who previously tested negative for BRCA1 and BRCA2 point mutations and small insertions/deletions. Positive MLPA result was confirmed and located by long-range PCR. The breakpoints of the candidate rearrangement were characterized by sequencing. A novel deletion of BRCA1 exon 21 (c.5277 + 480_5332 + 672del) was detected in 1 out of 352 Nigerian breast cancer patients (0.3% occurrence frequency). Further analysis of breakpoints revealed that the deletion involves two Alu-elements: one AluSg in intron 20 and the AluY in intron 21. These data suggest that while BRCA1 genomic rearrangement exists, they do not contribute significantly to BRCA1-associated risk in the Nigerian population.
Literature
1.
go back to reference Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene brca1. Science 266(5182):66–71CrossRefPubMed Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene brca1. Science 266(5182):66–71CrossRefPubMed
2.
go back to reference Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene brca2. Nature 378(6559):789–792. doi:10.1038/378789a0 CrossRefPubMed Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene brca2. Nature 378(6559):789–792. doi:10.​1038/​378789a0 CrossRefPubMed
4.
go back to reference Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies brca1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67(4):841–850CrossRefPubMed Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies brca1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67(4):841–850CrossRefPubMed
5.
go back to reference Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RK, Meindl A (2008) Mlpa screening in the brca1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29(7):948–958. doi:10.1002/humu.20723 CrossRefPubMed Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RK, Meindl A (2008) Mlpa screening in the brca1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29(7):948–958. doi:10.​1002/​humu.​20723 CrossRefPubMed
8.
go back to reference De la Hoya M, Gutierrez-Enriquez S, Velasco E, Osorio A, Sanchez de Abajo A, Vega A, Salazar R, Esteban E, Llort G, Gonzalez-Sarmiento R, Carracedo A, Benitez J, Miner C, Diez O, Diaz-Rubio E, Caldes T (2006) Genomic rearrangements at the brca1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52(8):1480–1485. doi:10.1373/clinchem.2006.070110 CrossRefPubMed De la Hoya M, Gutierrez-Enriquez S, Velasco E, Osorio A, Sanchez de Abajo A, Vega A, Salazar R, Esteban E, Llort G, Gonzalez-Sarmiento R, Carracedo A, Benitez J, Miner C, Diez O, Diaz-Rubio E, Caldes T (2006) Genomic rearrangements at the brca1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52(8):1480–1485. doi:10.​1373/​clinchem.​2006.​070110 CrossRefPubMed
9.
go back to reference Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, Koehler R, Janssen B, Bartram CR, Arnold N, Zschocke J (2004) Large brca1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24(6):534. doi:10.1002/humu.9291 CrossRefPubMed Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, Koehler R, Janssen B, Bartram CR, Arnold N, Zschocke J (2004) Large brca1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24(6):534. doi:10.​1002/​humu.​9291 CrossRefPubMed
10.
go back to reference Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D’Andrea E (2003) Genomic rearrangements account for more than one-third of the brca1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12(9):1055–1061CrossRefPubMed Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D’Andrea E (2003) Genomic rearrangements account for more than one-third of the brca1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12(9):1055–1061CrossRefPubMed
11.
go back to reference Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, Chiquette J, Laframboise R, Lepine J, Lesperance B, Pichette R, Plante M, Provencher L, Voyer P, Goldgar D, Bridge P, Simard J (2006) No evidence of brca1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 10(2):104–115. doi:10.1089/gte.2006.10.104 CrossRefPubMed Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, Chiquette J, Laframboise R, Lepine J, Lesperance B, Pichette R, Plante M, Provencher L, Voyer P, Goldgar D, Bridge P, Simard J (2006) No evidence of brca1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 10(2):104–115. doi:10.​1089/​gte.​2006.​10.​104 CrossRefPubMed
12.
go back to reference Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the brca1 and brca2 genes: review of the literature and report of a novel brca1 mutation. Breast Cancer Res Treat. doi:10.1007/s10549-010-0817-z Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the brca1 and brca2 genes: review of the literature and report of a novel brca1 mutation. Breast Cancer Res Treat. doi:10.​1007/​s10549-010-0817-z
13.
go back to reference Puget N, Torchard D, Serova-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM, Mazoyer S (1997) A 1-kb alu-mediated germ-line deletion removing brca1 exon 17. Cancer Res 57(5):828–831PubMed Puget N, Torchard D, Serova-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM, Mazoyer S (1997) A 1-kb alu-mediated germ-line deletion removing brca1 exon 17. Cancer Res 57(5):828–831PubMed
15.
go back to reference Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in brca1 and brca2 in high-risk breast cancer families. Cancer Res 68(17):7006–7014. doi:10.1158/0008-5472.CAN-08-0599 CrossRefPubMed Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in brca1 and brca2 in high-risk breast cancer families. Cancer Res 68(17):7006–7014. doi:10.​1158/​0008-5472.​CAN-08-0599 CrossRefPubMed
16.
go back to reference Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene brca1. Genome Res 6(11):1029–1049CrossRefPubMed Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene brca1. Genome Res 6(11):1029–1049CrossRefPubMed
Metadata
Title
Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population
Authors
Jing Zhang
James D. Fackenthal
Dezheng Huo
Yonglan Zheng
Olufunmilayo I. Olopade
Publication date
01-11-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1006-9

Other articles of this Issue 2/2010

Breast Cancer Research and Treatment 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine